Anticoagulation and post-phlebographic thrombosis.
D003974:Diatrizoate Meglumine / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008794:Metrizoic Acid / Q000009:adverse effects / Q000031:analogs & derivatives; D010690:Phlebography / Q000009:adverse effects*; D013924:Thrombophlebitis / Q000139:chemically induced / Q000517:prevention & control*
D003974:Diatrizoate Meglumine; D006493:Heparin; D008794:Metrizoic Acid; C021342:methylglucamine metrizoate